PROTAC BTK/IKZF1/3 Degrader-1

Overview

PROTAC BTK/IKZF1/3 Degrader-1 is a selective and orally active BCL6 and IKZF1/3 PROTAC degrader. PROTAC BTK/IKZF1/3 Degrader-1 exhibits antitumor activity. PROTAC BTK/IKZF1/3 Degrader-1 can be used for the research of cancer , such as lymphoma. (Structure Note: Pink: BCL6/IKZF1/3 ligand ( HY-179076 ); Blue: CRBN ligand ( HY-41547 )) (Pink: Btk and IKZF1 and IKZF3 ligand ( HY-179076 ); Blue: Cereblon ligand ( HY-41547 ); Black: linker).

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > PROTAC | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer | Products > Signaling Pathways > PROTACs | Products > Signaling Pathways > Btk | Products > Signaling Pathways > IKZF Family

Product Information

• Catalog No.: HY-179077
• CAS No.: 2416130-49-7
• Molecular Formula: C43H51N11O6
• Molecular Weight: 817.94
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source